Impact of Insulin Resistance on Silent and Ongoing Myocardial Damage in Normal Subjects: The Takahata Study

Table 1

Comparisons of clinical characteristics of 2200 subjects.

Age (years)*	69.1 ± 12.6
Gender (male/female)	973/1227
BMI (kg/m^2)*	23.0 ± 3.3
sBP (mm Hg)*	134 ± 16
dBP (mm Hg)*	79 ± 10
BNP (pg/mL)**	20.0 (10.9–35.8)
TC (mg/dL)**	200 (179–221)
TG (mg/dL)**	91 (68–125)
HDLc (mg/dL)*	59 ± 15
LDLc (mg/dL)*	124 ± 29
eGFR (mL/min/1.73 m^2)**	96 (82–110)
H-FABP (ng/mL)**	3.5 (2.6–4.7)

BMI: body mass index; BNP: brain natriuretic peptide; TC: total cholesterol; TG: triglyceride; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; H-FABP: heart type fatty acid binding protein; sBP: systolic blood pressure; dBP: diastolic blood pressure; Data are presented as *mean ± S.D; **median (interquartile range).